Danielle Brown1, Michael Watson2, Janet Schloss2. 1. Endeavour College of Natural Health, Brisbane, Queensland, Australia. name.danielle@icloud.com. 2. Endeavour College of Natural Health, Brisbane, Queensland, Australia.
Abstract
PURPOSE: This systematic literature review examines research into the use of medicinal cannabis in cancer management. The aim was to identify the gaps in knowledge on the dose, dosing schedule and absorption of the administration routes of medicinal cannabis use in oncology. METHODS: A comprehensive search of the literature was conducted across six databases to identify original data reporting the pharmacology of medicinal cannabis in oncology. RESULTS: Eighteen articles were selected for review. Of the selected articles, ten were identified as randomised control trials, two experimental studies, two retrospective cohort studies and four case studies. Four articles reported absorption data and one drug interaction study was identified. CONCLUSIONS: There is little evidence reported in the literature on the absorption of medicinal cannabis in cancer populations. Various reasons are explored for the lack of pharmacokinetic studies for medicinal cannabis in cancer populations, including the availability of assays to accurately assess cannabinoid levels, lack of clinical biomarkers and patient enrolment for pharmacokinetic studies.
PURPOSE: This systematic literature review examines research into the use of medicinal cannabis in cancer management. The aim was to identify the gaps in knowledge on the dose, dosing schedule and absorption of the administration routes of medicinal cannabis use in oncology. METHODS: A comprehensive search of the literature was conducted across six databases to identify original data reporting the pharmacology of medicinal cannabis in oncology. RESULTS: Eighteen articles were selected for review. Of the selected articles, ten were identified as randomised control trials, two experimental studies, two retrospective cohort studies and four case studies. Four articles reported absorption data and one drug interaction study was identified. CONCLUSIONS: There is little evidence reported in the literature on the absorption of medicinal cannabis in cancer populations. Various reasons are explored for the lack of pharmacokinetic studies for medicinal cannabis in cancer populations, including the availability of assays to accurately assess cannabinoid levels, lack of clinical biomarkers and patient enrolment for pharmacokinetic studies.
Authors: Aminah Jatoi; Harold E Windschitl; Charles L Loprinzi; Jeff A Sloan; Shaker R Dakhil; James A Mailliard; Sarode Pundaleeka; Carl G Kardinal; Tom R Fitch; James E Krook; Paul J Novotny; Brad Christensen Journal: J Clin Oncol Date: 2002-01-15 Impact factor: 44.544
Authors: Frederike K Engels; Floris A de Jong; Alex Sparreboom; Ron A A Mathot; Walter J Loos; Jos J E M Kitzen; Peter de Bruijn; Jaap Verweij; Ron H J Mathijssen Journal: Oncologist Date: 2007-03
Authors: Eyal Meiri; Haresh Jhangiani; James J Vredenburgh; Luigi M Barbato; Frederick J Carter; Hwa-Ming Yang; Vickie Baranowski Journal: Curr Med Res Opin Date: 2007-03 Impact factor: 2.580
Authors: M Guzmán; M J Duarte; C Blázquez; J Ravina; M C Rosa; I Galve-Roperh; C Sánchez; G Velasco; L González-Feria Journal: Br J Cancer Date: 2006-06-27 Impact factor: 7.640
Authors: Pietro Brunetti; Simona Pichini; Roberta Pacifici; Francesco Paolo Busardò; Alessandro Del Rio Journal: Medicina (Kaunas) Date: 2020-05-15 Impact factor: 2.430
Authors: Billy Vinette; José Côté; Ali El-Akhras; Hazar Mrad; Gabrielle Chicoine; Karine Bilodeau Journal: BMC Cancer Date: 2022-03-24 Impact factor: 4.430